SRSF1 Prevents DNA Damage and Promotes Tumorigenesis through Regulation of DBF4B Pre-mRNA Splicing

Publication date: 19 December 2017
Source:Cell Reports, Volume 21, Issue 12
Author(s): Linlin Chen, Chunling Luo, Lei Shen, Yuguo Liu, Qianqian Wang, Chang Zhang, Ruochen Guo, Yanan Zhang, Zhiqin Xie, Ning Wei, Wenwu Wu, Jun Han, Ying Feng
Dysregulated alternative splicing events have been implicated in many types of cancer, but the underlying molecular mechanisms remain unclear. Here, we observe that the splicing factor SRSF1 regulates DBF4B exon6 splicing by specifically binding and promoting its inclusion. Knockdown of the exon6-containing isoform (DBF4B-FL) significantly inhibits the tumorigenic potential of colon cancer cells in vitro and in mice, and SRSF1 inactivation phenocopies DBF4B-FL depletion. DBF4B-FL and SRSF1 are required for cancer cell proliferation and for the maintenance of genomic stability. Overexpression of DBF4B-FL can protect against DNA damage induced by SRSF1 knockdown and rescues growth defects in SRSF1-depleted cells. Increased DBF4B exon6 inclusion parallels SRSF1 upregulation in clinical colorectal cancer samples. Taken together, our findings identify SRSF1 as a key regulator of DBF4B pre-mRNA splicing dysregulation in colon cancer, with possible clinical implications as candidate prognostic factors in cancer patients.

Graphical abstract

Teaser

Chen et al. find that SRSF1 is a key regulator of DBF4B pre-mRNA splicing in colon cancer cells and demonstrates that SRSF1 prevents DNA damage and promotes tumorigenesis through its regulation of a DBF4B-FL splice variant.


http://ift.tt/2ksWaAE